Clinical Trial Update: Neoadjuvant Cisplatin/Docetaxel (CDDP/TXT) and Chemoradiation for Head and Neck Cancer [Phase 1, Phase 2]

View source ↗

Summary

This document provides an update on a Phase 1/2 clinical trial evaluating neoadjuvant cisplatin/docetaxel followed by chemoradiation for head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Cisplatin (Platinol) (cisplatin)
• Docetaxel (Taxotere) (docetaxel)

Snippet

Sponsor: University of Vermont | Conditions: Head and Neck Neoplasms | Phase 1, Phase 2 | Status: UNKNOWN